AvKARE Rosuvastatin Tablets 10mg Recall: Dissolution Issue
AvKARE recalls 10mg Rosuvastatin tablets due to dissolution problems. This may affect medication effectiveness. Check NDC 50268-709-15 and lot #49124 for affected products.
Lower-risk recall
Out of specification for dissolution.
Contact the company
What happened, in plain English
AvKARE is recalling 10mg Rosuvastatin tablets that may not dissolve properly. This could lead to inconsistent medication effectiveness. Affected products have specific NDC and lot numbers. Read more at govinfonow.com/recall/31566-avkare-rosuvastatin-tablets-10mg-recall-dissolution-issue.
Source Summary by GovInfoNow · govinfonow.com/recall/31566-avkare-rosuvastatin-tablets-10mg-recall-dissolution-issue · Updated August 17, 2026 · FDA enforcement record: FDA #D-0292-2026
Cite this page
“AvKARE Rosuvastatin Tablets 10mg Recall: Dissolution Issue.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/31566-avkare-rosuvastatin-tablets-10mg-recall-dissolution-issue. Based on FDA recall #D-0292-2026 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0292-2026%22&limit=1).
Why it’s dangerous
The tablets may not dissolve correctly, which could affect how well the medication works. This is a quality issue that might lead to inconsistent drug levels in the body.
Who’s affected
People with prescriptions for AvKARE Rosuvastatin tablets. Those who have the specific NDC 50268-709-15 and lot #49124 are most at risk.
How to tell if you have this one
Check for NDC code 50268-709-15 and lot number 49124 on the packaging. The product was manufactured in Pulaski, TN and expires December 31, 2026.
- Brand
AvKARE- Category
Drug
What to do — step by step
Check Product Details
Look for NDC 50268-709-15 and lot #49124 on the packaging.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide in the USA” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA published this recall 14 days after the firm started it.
- Firm started the recall
- Published in FDA’s Enforcement Report
- FDA classified it Class II
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0292-2026 (December 31, 2025) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0292-2026 to see it in context.
- Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.